Skye Bioscience Inc.(SKYE) - 2025 Q2 - Quarterly Results

Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update SAN DIEGO, CA, August 7, 2025 -- Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company"), a clinical stage biotechnology company developing next-generation molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related conditions, today reported financial results for the second quarter ended June 30, 2025, along with key accomplishments and upcoming milestones. "As we eagerly await the 26- ...